http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018521813-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36107
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2016-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2018521813-A
titleOfInvention System and method for treatment of bladder dysfunction
abstract Methods and systems for providing treatment related to urinary system disorders are described. Certain embodiments of the present technology relate to stimulation of the saphenous nerve (SAFN) either alone or in combination with the posterior tibial nerve (PTN), medial plantar nerve (MPN), or lateral plantar nerve. . In embodiments, the nerve is stimulated by a transcutaneous stimulator, a transcutaneous stimulator, and / or an implantable stimulator. In an embodiment, the SAFN is stimulated below the knee level or close to the adrenal gland. Embodiments also illustrate that systems and methods named improved transcutaneous electrical stimulation (eTENS) enhance neural tissue excitement and are therefore used to improve neural stimulation, including SAFN stimulation. To do. In embodiments, systems and methods are provided to increase the likelihood of providing selective modulation of specific (target) neural substrates while reducing the risk of activation of adjacent (non-target) neural tissue. [Selection] Figure 10b
priorityDate 2015-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009326602-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008154334-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013006322-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414883544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423056541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22908568

Total number of triples: 27.